The National Academies will host a workshop exploring the transformative potential of artificial intelligence (AI) and machine learning (ML) in chemical sciences and drug discovery. Researchers, policymakers, and stakeholders will examine how to address data biases and democratize pharmaceutical research to potentially reduce drug development costs. This AI focused workshop will discuss expanding research capacity, particularly for rare diseases, while exploring challenges such as preventing healthcare disparities and ensuring access to advanced technological resources. Panel discussions will feature thought leaders examining the integration of AI, laboratory automation, and robotics to advance the chemical sciences' role in traditional drug discovery.